Stage-specific embryogenic antigen-4 expression in castration-resistant prostate cancer and its correlation with the androgen receptor

0Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Background/Aim: Stage-specific embryonic antigen (SSEA)-4 plays important roles in the malignant aggressiveness of various cancers. The aim of this study was to investigate the pathological characteristics of SSEA-4 in castration-resistant prostate cancer (CRPC). Materials and Methods: SSEA-4 expression and its pathological roles were evaluated in five prostate cancer (PC) cell lines and 27 CRPC tissues. The relationship between SSEA-4 and the androgen receptor (AR) was also examined. Results: SSEA4 expression was detected in AR-negative cells (PC3, DU145, and AICaP1) but was not detected in AR-positive cells (LNCaP and AICaP2). SSEA-4 expression in human CRPC tissues was significantly higher than that in locally advanced or metastatic hormone sensitive PC (HSPC) tissues. A negative correlation was also detected between SSEA-4 and AR in CRPC tissues but not in HSPC tissues. Conclusion: SSEA-4 was over-expressed in CRPC and the changes were mediated by complex mechanisms that related to the AR and hormonal therapy.

Cite

CITATION STYLE

APA

Harada, J., Miyata, Y., Taima, T., Matsuda, T., Mukae, Y., Mitsunari, K., … Saito, S. (2021). Stage-specific embryogenic antigen-4 expression in castration-resistant prostate cancer and its correlation with the androgen receptor. Anticancer Research, 41(7), 3327–3335. https://doi.org/10.21873/anticanres.15120

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free